Work

Phase I study of pexidartinib (PLX3397) in children with refractory leukemias and solid tumors including neurofibromatosis type I (NF1) related plexiform neurofibromas (PN).

Year: 2017

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2017.35.15_suppl.10546

Authors: Lauren Hittson, John Glod, Melissa Amaya, Joanne Derdak, Brigitte C. Widemann, Rosandra N. Kaplan

Institutions: National Institutes of Health, National Cancer Institute, Center for Cancer Research

Language: English

Topic: Neurofibromatosis and Schwannoma Cases

Subfield: Neurology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2891310451

Cites:

Cited by: 8

Related to: 10